Over 2,000+ real adjudications. Browse free — subscribe to search by company, clause and case reference.
1,914 cases · Unlock search, clause & company filters ↓
Takeda’s Competact mailer claimed it was uniquely cheaper than its constituent parts. After a January Drug Tariff change, Avandamet was…
GSK’s HCP webinar registration page about fluticasone furoate was deemed promotional for Relvar Ellipta but omitted prescribing information. Breach of…
Ivax cited an Italian carbocysteine lysine study (Fluifort) to support Mucodyne COPD claims. The Panel said the products/dosing weren’t shown…
A GP received a Univadis mailing containing username/password in an envelope not marked confidential, despite asking to deregister. Panel found…
Complaint about Daily Telegraph articles referencing Victoza. PMCPA found the matter outwith the scope of the ABPI Code; no breach…
Complaint about alleged promotion of Cialis. PMCPA recorded no breach because the matter was outwith the scope of the Code;…
CCG alleged a Novo Nordisk rep asked a receptionist to add a handwritten Victoza claim about use at eGFR <15.…
A Pulse ad for fluoxetine used the broad claim “for treatment of depressive illness”. PMCPA ruled it didn’t accurately reflect…
Vifor’s reps used materials implying Ferinject had fewer ADRs than Monofer. A follow-up “medical information” email was ruled promotional, misleading…
A global Ipsen LinkedIn post featuring a UK-based employee quote linked to an ENGAGE study press release. PMCPA said this…
Anonymous complaint alleged off-licence, misleading and disguised promotion at a Janssen-sponsored oncology meeting. Panel ruled no breach as allegations lacked…
A UK health professional said a Duac 5% Pulse Today banner was static and lacked prescribing info. GSK said it…
Complaint about a third-party provider’s internal email linking Bayer’s AF therapy review service to Xarelto. Panel found breach of Clause…
At a fertility conference, Saxenda materials and patient brochure lacked clear, prominent pregnancy/trying-to-conceive warnings. Appeal Board found misleading safety presentation,…
A Ferring-sponsored nocturia supplement with UK Nocdurna prescribing info stayed accessible online for 2.5+ years beyond its Dec 2017 end…
A Steglatro formulary decision guide intended for HCPs was visible through transparent wrappers used for some mailed journals. MSD admitted…
A patient complained about a YouTube-hosted meeting recording mentioning Lixiana. Most allegations were not upheld, but Daiichi-Sankyo was found in…
A national newspaper osteoporosis awareness ad “supported by Amgen” was not POM promotion, but was ruled misleading for implying patients…
Anonymous employee alleged poor diabetes rep training and over-reliance on a fellow representative. Panel found complaint unproven on balance of…
Anonymous ex-employee alleged Lecigon advisory boards were marketing-led/disguised promotion and that a nursing service was compromised by sales access to…
Members can instantly filter all 2,000+ cases by any of the 154 PMCPA clauses and 291 pharmaceutical companies — plus get video walkthroughs, expert podcasts and CPD certificates for every case.
One real case. One key lesson. Every week — free.